Symbiotec Pharmalab Ltd (SYMBIOTEC) — Board Meeting | 21 September 2026

21 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved unaudited Q3 FY2026 financial results and IPO listing confirmation

🔄 What Changed

Approved unaudited financial results for Q3 FY2026 and confirmed IPO listing on BSE/NSE

🔮 What's Next

IPO proceeds utilization update to be provided in next reporting period

💡 Investor Takeaway

The company completed its IPO and published unaudited quarterly financial results, indicating market readiness and operational transparency.

The Board of Directors of Symbiotec Pharmalab approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report from SR BC & CO LLP, and confirmed the company's recent IPO listing on BSE and NSE effective September 1, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SYMBIOTEC ✨ Ask AI About This

About Symbiotec Pharmalab Ltd (SYMBIOTEC)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹6,629.52 Cr

View full SYMBIOTEC stock details →

📡 Get AI alerts when SYMBIOTEC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SYMBIOTEC — Free

💡 Ask AI about this filing

"What is the utilization status of IPO proceeds?""How does the IPO impact shareholding structure?""What is the projected revenue growth for FY2027?"

Ask AI Free →

📊 More SYMBIOTEC filings

🔴 Announcement — 29 September 2026Symbiotec Pharmalab announced it received a U.S. FDA Establishment Inspection Report for its Pithamp...
Announcement — 29 September 2026Symbiotec Pharmalab announced that its trading window closes on October 1, 2026, for insiders until ...
🔴 Announcement — 28 September 2026Symbiotec Pharmalab reported Q1 FY27 revenue of INR218 crores, up 7% YoY, driven by 6% growth in its...
🔴 Announcement — 22 September 2026Symbiotec Pharmalab announced that the audio recording of its Q1 FY2026 earnings conference call is ...
🔴 Announcement — 17 September 2026Symbiotec Pharmalab announced an analyst and investor conference call on September 22, 2026 at 10:00...

See all SYMBIOTEC filings →

🔥 Also filed on 21 September 2026

BIOCONBiocon LtdAnnouncement 523373Mini Diamonds (India) LtdAnnouncement PATANJALIPatanjali Foods LtdAnnouncement PREMIERENEPremier Energies LtdAnnouncement 544900Complete Sports and Management India LimitedAnnouncement MCLOUDMagellanic Cloud LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SYMBIOTEC files new disclosures

Track SYMBIOTEC filings, board meetings, and corporate actions. Free email alerts at 5 PM.